An unusual cutaneous-polyposis syndrome stabilized with acitretin.
We present a patient with an unusual enterocutaneous syndrome. Long-term, low-dose acitretin treatment has stabilized the development of gastrointestinal lesions while synchronously reducing cutaneous morbidity.
Schmulewitz
L
L
Department of Dermatology, Chelsea and Westminster Hospital NHS Foundation Trust, London SW10 9NH, UK.
Attard
N
N
Fearfield
L
L
Westaby
D
D
Prasad
P
P
Thomas
H J W
HJ
Bunker
C B
CB
D017255:Acitretin / Q000008:administration & dosage*; D018256:Adenomatous Polyps / Q000175:diagnosis / Q000188:drug therapy*; D002294:Carcinoma, Squamous Cell / Q000175:diagnosis / Q000188:drug therapy*; D005260:Female; D052138:Genes, Neoplasm / Q000235:genetics; D006801:Humans; D044483:Intestinal Polyposis / Q000175:diagnosis / Q000188:drug therapy*; D007641:Keratolytic Agents / Q000008:administration & dosage*; D008099:Liver / Q000201:enzymology; D008875:Middle Aged; D012878:Skin Neoplasms / Q000175:diagnosis / Q000188:drug therapy*; D013577:Syndrome; D016896:Treatment Outcome
D007641:Keratolytic Agents; D017255:Acitretin